In COVID-19, pulmonary edema has been attributed to “cytokine storm”. However, it is
known that SARS-CoV2 promotes angiotensin-converting enzyme 2 deficit, increases …

Favipiravir displays a rapid viral clearance, a high recovery rate and broad therapeutic
safety; however, its oral administration was associated with systemic side effects in …

In response to the urgent need for effective treatments during the rapid spread and high
mortality rate of COVID-19, existing drugs were repurposed for potential antiviral effects …

Background Coronavirus disease 2019 (COVID-19) has created the need to evaluate drugs
such as favipiravir (FPV), an antiviral inhibitor of RNA-dependent RNA-polymerase (RdRp) …

Key Clinical Message The purpose of this case report is to reveal one of the cardiovascular
side effects of favipiravir, sinus bradycardia. Abstract Favipiravir has emerged as a potential …

BACKGROUND Cardiac arrhythmias, including bradyarrhythmias, have been described as
manifestations of coronavirus disease 2019 (COVID-19). Herein, we present a case of …

Abstract The coronavirus disease 2019 (COVID-19) may lead to a wide spectrum of clinical
manifestations ranging from asymptomatic to symptomatic by having targets on various …

Összefoglaló. A koronavírus–19-pandémia hatalmas kihívás az egészségügyi
ellátórendszerek számára. A hatékony kezelés iránti igény felerősítette a terápiás …

Цель исследования—оценить ассоциации различных вариантов генов AOX1 и CYP1A2
с параметрами безопасности терапии фавипиравиром у пациентов с COVID-19 …

Introducción: SARS-CoV-2 emergió como un nuevo agente viral que rápidamente se
diseminó a nivel mundial, responsable de la enfermedad por coronavirus humano 2019 …